MedTrace Logo

The Impact of Routine Measurement of Cardiac Troponin (hsTnT) on Outcome in Elderly Patients Undergoing Major Surgery

NCT03605134 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2025-11-18

No results posted yet for this study

Summary

To document levels of cardiac troponin hsTnT in patients above 75y undergoing high risk surgery and the relationship between elevated levels and outcome in terms of hospital stay and 30 day mortality.

Conditions

  • Surgery--Complications
  • Mortality
  • Elderly

Interventions

DIAGNOSTIC_TEST

level of cardiac troponin

blood test

DIAGNOSTIC_TEST

diastolic function assessment

transthoracic echocardiography

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • jan Poelaert, PhD, MD · Universitair Ziekenhuis Brussel

  • Patrice Forget, PhD, MD · Universitair Ziekenhuis Brussel

Eligibility

Min Age
75 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-23
Primary Completion
2019-08-07
Completion
2019-08-07

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03605134 on ClinicalTrials.gov